Molecular pathogenesis of disease progression in MLL-rearranged AML.

MLA

Kotani, Shinichi, et al. “Molecular Pathogenesis of Disease Progression in MLL-Rearranged AML.” Leukemia, vol. 33, no. 3, Mar. 2019, pp. 612–24. EBSCOhost, https://doi.org/10.1038/s41375-018-0253-3.

APA

Kotani, S., Yoda, A., Kon, A., Kataoka, K., Ochi, Y., Shiozawa, Y., Hirsch, C., Takeda, J., Ueno, H., Yoshizato, T., Yoshida, K., Nakagawa, M. M., Nannya, Y., Kakiuchi, N., Yamauchi, T., Aoki, K., Shiraishi, Y., Miyano, S., Maeda, T., … Makishima, H. (2019). Molecular pathogenesis of disease progression in MLL-rearranged AML. Leukemia, 33(3), 612–624. https://doi.org/10.1038/s41375-018-0253-3

Chicago

Kotani, Shinichi, Akinori Yoda, Ayana Kon, Keisuke Kataoka, Yotaro Ochi, Yusuke Shiozawa, Cassandra Hirsch, et al. 2019. “Molecular Pathogenesis of Disease Progression in MLL-Rearranged AML.” Leukemia 33 (3): 612–24. doi:10.1038/s41375-018-0253-3.